DH further procures additional seasonal influenza vaccines to meet current demand
*********************************************************************************
The DH has been closely liaising with the Hospital Authority (HA) on the demand for influenza vaccines. The DH will continue to closely monitor the demand for influenza vaccine and procure extra vaccines from vaccine suppliers as indicated.
On the supply of vaccines in the local private healthcare sector, the DH has been closely in touch with the vaccine suppliers and received confirmation from one vaccine supplier that extra quantities of quadrivalent SIVs have already been allocated and dispatched to the local private healthcare sector since last Friday and the provision is expected to be completed before the Chinese New Year (CNY). A new batch of vaccines will also arrive in Hong Kong in mid-March.
In addition, another vaccine supplier has also allocated extra quantities of quadrivalent SIVs, which are expected to become available to the local private healthcare sector after the CNY.
"To combat the influenza season, the SIVs used in Hong Kong were manufactured based on the latest recommendations from the World Health Organization for the northern hemisphere vaccine of 2017/18 season. The vaccines are valid up to mid-2018, but not the stock left from the last influenza season as alleged," the spokesman reiterated.
Before the launch of 2017/18 GVP, the Government has contracted to purchase around 460 000 doses of SIVs, an increase of around 30 000 doses over the 2016/17 procurement.
For details on the GVP and the Vaccination Subsidy Scheme, the public may call the CHP's hotline (2125 2125) or visit the Vaccination Schemes page.
Ends/Friday, February 9, 2018
Issued at HKT 22:18
Issued at HKT 22:18
NNNN